Dose Insider / Glossary / Missed dose

Missed doseWhat each GLP-1 label says to do

Updated November 20, 2026 · 4 min read · FDA and DailyMed labels of 8 GLP-1 medicines, 2025-2026

A missed dose is a scheduled dose of a medicine that was not taken on time. For GLP-1 medicines the label of each product says what to do, and the rules differ. A missed weekly Ozempic shot can be given within 5 days and a missed Zepbound or Mounjaro shot within 4 days, while a missed daily tablet of Rybelsus or Wegovy is simply skipped.

5 daysOzempic, how late a weekly dose can be
How late a weekly dose can beDays after the missed day, from each labelOzempic5 daysWegovyabout 5 daysZepbound, Mounjaro4 daysTrulicityabout 4 daysHow late a weekly dose canbeDays after the missed day, from each labelOzempic5 daysWegovyabout 5 daysZepbound, Mounjaro4 daysTrulicityabout 4 days

After that window, the missed dose is skipped.

On this page

Several labels also say when a gap is long enough that the dose has to climb again from a lower step.1,2,3,4,5

Weekly injections

MedicineTake the missed dose ifOtherwise
OzempicWithin 5 days of the missed daySkip it
Wegovy injectionThe next dose is more than 2 days awaySkip it
Zepbound, MounjaroWithin 4 days, or 96 hoursSkip it
TrulicityThe next dose is at least 3 days, or 72 hours, awaySkip it

Section 2 of each label.1,2,3,6

The Wegovy and Trulicity rules count back from the next dose rather than forward from the missed one, but they work out much the same. With a week between doses, a Wegovy dose whose next one is more than 2 days away is no more than about 5 days late. A Trulicity dose with at least 3 days to go is no more than about 4 days late. In every case, after the missed dose is taken or skipped, the regular weekly day continues.1,2,3,6

The Wegovy label adds a rule for longer gaps: if 2 or more doses in a row are missed, the climb restarts at a lower dose to reduce the risk of stomach and gut side effects.2 Our page on missed doses of Zepbound and Wegovy works through the calendar case by case.

Daily tablets and injections

The difference between skipping and making up follows from timing. A daily tablet taken late would push the next one close behind it, and the semaglutide tablets must be taken on an empty stomach in the morning, so the labels simply move on to the next day.4

Why a long gap matters

The climb in dose at the start of treatment exists to reduce stomach and gut side effects, as each label says. After a long break the body has partly lost that adjustment, which is why several labels send people back to a lower step rather than straight to their usual dose.2,5,7

How long the medicine lingers also matters. Semaglutide has a half-life of about 1 week and stays in the circulation for about 5 weeks after the last dose; tirzepatide has a half-life of about 5 days.1,3 So a single missed weekly dose lowers the level in the blood but does not empty it. Our page on timing a weekly GLP-1 shot shows the level before and after a late dose.

Changing the injection day

A related rule covers moving the weekly day on purpose. On Ozempic and Wegovy the day can change if the last dose was at least 2 days before; on Zepbound and Mounjaro the gap between the two doses must be at least 3 days, or 72 hours.1,2,3

Practical points

Sources

  1. OZEMPIC (semaglutide) injection prescribing information, NDA 209637/S-039, revised May 2026. U.S. Food and Drug Administration; sections 2.1 and 12.3. accessdata.fda.gov
  2. WEGOVY (semaglutide) prescribing information, NDA 215256/S-025, revised June 2026. U.S. Food and Drug Administration; sections 2 and 17, with the Medication Guide. accessdata.fda.gov
  3. ZEPBOUND (tirzepatide) prescribing information, NDA 217806/S-041, revised August 2026, sections 2 and 12.3; and MOUNJARO (tirzepatide) prescribing information, NDA 215866/S-052, revised April 2026, section 2. U.S. Food and Drug Administration. accessdata.fda.gov
  4. RYBELSUS and OZEMPIC (semaglutide) tablets prescribing information, revised January 2026. Novo Nordisk; DailyMed, version published August 19, 2026; section 2. dailymed.nlm.nih.gov
  5. FOUNDAYO (orforglipron) tablets prescribing information. Eli Lilly and Company; DailyMed, version published August 13, 2026; section 2. dailymed.nlm.nih.gov
  6. TRULICITY (dulaglutide) injection prescribing information. Eli Lilly and Company; DailyMed, version published August 10, 2026; section 2.3. dailymed.nlm.nih.gov
  7. SAXENDA (liraglutide) injection prescribing information. Novo Nordisk; DailyMed, version published June 15, 2026; section 2.1. dailymed.nlm.nih.gov

Related analyses

Log each dose and get the label's window for a missed one worked out on your calendar.

Open Dose Insider